Skip to content
MyFreud

Trazodone for Sleep: What Studies Show

Trazodone is an antidepressant widely prescribed for insomnia. What a 45-study review, a small trial against CBT-I and a network meta-analysis found.

5 min read

Flat vector illustration of a woman in a pink robe and a white head wrap wearing a sheet face mask, propped on green pillows in bed and reading a book, with a lit candle and a clock on the bedside table.

Key takeaways

  • A systematic review of 45 studies found that trazodone is approved as an antidepressant, that its off-label use for insomnia has surpassed its use for depression, and that evidence for its efficacy has been repeatedly demonstrated, with dose-dependent side-effects, drowsiness being the most common.
  • The reviewers concluded that adequate data support the efficacy and general safety of low-dose trazodone for insomnia, but that conclusion rests on a mix of study designs, including observational studies, rather than on one large controlled trial.
  • In a small randomised trial of 15 people with chronic insomnia and objectively short sleep, trazodone but not cognitive behavioural therapy for insomnia (CBT-I) lengthened total sleep time by about 51 minutes, though the trial was preliminary and open-label.
  • A 2022 network meta-analysis of 154 trials listed trazodone among many licensed drugs that can be effective in acute insomnia but are associated with poor tolerability, or lack information about long-term effects.
  • These are averages from limited studies, none of which tells you which dose or for how long, and none replaces advice from a prescriber who knows your other medicines and health.

Trazodone is an antidepressant that is widely used off-label for insomnia, and the research suggests it can help at low doses, though the evidence is small and mixed. A 2017 systematic review of 45 studies found its efficacy repeatedly demonstrated for insomnia, [jaffer-2017] while a 2022 network meta-analysis listed it among licensed drugs that can be effective in acute insomnia but are poorly tolerated or lack long-term data. [decrescenzo-2022-trazodone] This guide covers what the studies found, how trazodone compares with CBT for insomnia, what they could not show and what to ask a prescriber. Our guide to sleeping pills covers the other drugs, and our sleep overview covers the wider picture.

Does trazodone work for sleep?

The studies suggest it can, with limits on how firmly. The 2017 review searched 1983 to 2016 and included 45 studies of randomised trials, meta-analyses and observational and placebo-controlled studies of trazodone for primary or secondary insomnia. It found that evidence for efficacy has been repeatedly demonstrated for primary insomnia and for secondary insomnia, including symptoms resulting from depression and dementia. [jaffer-2017]

The reviewers concluded that adequate data support the efficacy and general safety of low-dose trazodone for insomnia. [jaffer-2017] The weakness is the mix: 45 studies across designs, going back decades, is not the same as one large modern trial.

The 2022 network meta-analysis, which compared drugs across 154 double-blind trials, took a more cautious line. Its interpretation was that many licensed drugs, including benzodiazepines, daridorexant, suvorexant and trazodone, can be effective in the acute treatment of insomnia but are associated with poor tolerability, or that information about long-term effects is not available. [decrescenzo-2022-trazodone]

Why is an antidepressant prescribed for sleep?

Because drowsiness is its most common side-effect, and it has been used off-label for years. Trazodone is approved for the treatment of depression, and the 2017 review noted that its off-label use for insomnia has surpassed its use as an antidepressant. [jaffer-2017]

Earlier studies from 1980 to 2000 used high doses of 100 mg a day or more in depressed people. Since the 2000s its use has widened to secondary insomnia in people who are not depressed, and the reviewers’ conclusion concerns low-dose use. [jaffer-2017]

What are the side-effects of trazodone for sleep?

They depend on the dose, and drowsiness is the most common. The 2017 review reported that side-effects are dose-dependent and concluded that low-dose use is generally safe on the available evidence. [jaffer-2017] That is a statement about a low dose in the studies reviewed, so what is right for you is a decision for a prescriber who knows your other medicines.

How does trazodone compare with CBT for insomnia?

A small trial found trazodone lengthened sleep more, in one specific group. It randomised 15 adults with chronic insomnia who also had objectively short sleep, 8 to CBT-I and 7 to trazodone, and measured sleep with wrist actigraphy. Trazodone, but not CBT-I, lengthened total sleep time after treatment (by 51.01 minutes versus a fall of 11.73 minutes, a difference that just missed the usual threshold for statistical significance) and at 6-month follow-up (by 50.35 minutes versus a fall of 7.56, which did reach it). [vgontzas-2020]

There were no differences between the groups on the Insomnia Severity Index, a self-rated score. The authors described the trial as preliminary and open-label, which means everyone knew which treatment they were getting, and the numbers are small. [vgontzas-2020] It tells you a drug and a talking therapy can work differently in one phenotype, and it does not show that either is better overall. Our guide to CBT for insomnia explains the behavioural treatment.

Questions worth taking to a prescriber

Tick anything that applies. This is a preparation prompt for a conversation about sleep medication, it cannot diagnose anything and it does not say whether trazodone is right for you.

0 of 6 ticked

QuestionWhat the studies foundCaveat
Does it work?Efficacy repeatedly demonstrated in 45 studiesMixed designs, mostly older
Compared with CBT-I?Longer sleep with trazodone in 15 peoplePreliminary, open-label
Side-effects?Dose-dependent, drowsiness most commonLow-dose focus
Long term?Information not available (2022 review)Unknown

What can this research not show?

It cannot show which dose is right, how long to take it or whether it suits you. Five limits matter most:

  • The main review mixes study designs. Its 45 studies include observational work and span 1983 to 2016, so it is not a single controlled trial. [jaffer-2017]
  • The comparison with CBT-I is tiny. Fifteen people, open-label and preliminary, in one phenotype of insomnia. [vgontzas-2020]
  • Long-term effects are unknown. The 2022 review said information on long-term effects was not available for several drugs, trazodone among them. [decrescenzo-2022-trazodone]
  • Side-effects are only partly described. We could verify that they are dose-dependent and that drowsiness is the most common, but not the full list or the interaction with other medicines. [jaffer-2017]
  • Averages hide individuals. Nothing here tells you how you will respond, and older adults, people on other medicines and people who drink were not the focus.

What should you ask a prescriber?

Ask what dose is planned and why, how long to take it, what the plan is for stopping and whether a course of CBT for insomnia can start first or alongside. This section is our suggestion and is not something the studies tested.

Useful questions are what to do about alcohol and other medicines, how it might affect driving the next day and what to do if it does not help. Our guides to sleeping pills, why you cannot sleep and sleep hygiene cover the surrounding options. Do not stop a prescribed sleep medicine suddenly without speaking to the prescriber.

When to seek help

Speak to a doctor if poor sleep has lasted three weeks or more, if it is affecting your days or mood, or if you are already taking trazodone and want to stop, or are having daytime drowsiness or side-effects. If you feel unable to stay safe, contact your local emergency services or a crisis helpline.

How MyFreud can help

A sleep record helps a prescriber more than a description from memory. Daily mood tracking in MyFreud shows how your days run over weeks, and the notepad is somewhere to note when you slept, what you took and how you felt the next day. It does not replace a doctor.

Download MyFreud and start today: App Store or Google Play.

Frequently asked questions

Does trazodone work for sleep?

The studies suggest it can help, with limits on how firmly. A systematic review of 45 studies found evidence for its efficacy repeatedly demonstrated in primary and secondary insomnia, and concluded adequate data support the efficacy and general safety of low-dose use. The evidence comes from a mix of designs, and a 2022 network meta-analysis noted poor tolerability or missing long-term data for several drugs, trazodone among them.

Why is trazodone prescribed for sleep if it is an antidepressant?

Because drowsiness is its most common side-effect, and it has been used off-label for years. Trazodone is approved to treat depression, and the 2017 systematic review noted that its off-label use for insomnia has surpassed its use as an antidepressant. Since the 2000s it has also been studied for insomnia in people who are not depressed.

What are the side-effects of trazodone for sleep?

The review found they are dose-dependent and that the most common is drowsiness. It concluded that low-dose use is generally safe on the data available, but its authors did not report on every possible side-effect, so ask a prescriber about daytime sleepiness, interactions with other medicines and alcohol, and what to watch for.

Is trazodone better than CBT for insomnia?

A small trial found it lengthened sleep more in one type of insomnia, but it is too small to settle the question. In 15 people with chronic insomnia and objectively short sleep, trazodone but not CBT-I increased total sleep time (about 51 minutes), while the two groups did not differ on insomnia severity scores. The authors called it preliminary and open-label.

Is it safe to take trazodone for sleep long term?

The research we could verify does not say. The 2022 network meta-analysis said information about long-term effects was not available for several drugs including trazodone, and the 45-study review concentrated on efficacy and general safety at low doses. How long to continue is a decision for you and a prescriber.

References

  1. 1.Jaffer KY, et al. ( 2017). Trazodone for insomnia: a systematic review. Innovations in Clinical Neuroscience. pubmed.ncbi.nlm.nih.gov .
  2. 2.Vgontzas AN, et al. ( 2020). Effects of trazodone versus cognitive behavioral therapy in the insomnia with short sleep duration phenotype: a preliminary study. Journal of Clinical Sleep Medicine. doi.org . doi:10.5664/jcsm.8740
  3. 3.De Crescenzo F, et al. ( 2022). Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. The Lancet. doi.org . doi:10.1016/S0140-6736(22)00878-9